Anaplastic lymphoma kinase (ALK) expression in lung adenocarcinoma - clinicopathologic and morphologic features

被引：0
|
作者：
Jasar, D. [1 ]
Kubelka-Sabit, K. [1 ]
Filipovski, V. [1 ,2 ]
机构：
[1] Clin Hosp Acibadem Sistina, Dept Histopathol & Cytol, Skopje, Macedonia
[2] Univ Goce Delchev, Fac Med, Shtip, Macedonia
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-22-00
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [31] Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosis
    Chun, YS
    Wang, LN
    Nascimento, AG
    Moir, CR
    Rodeberg, DA
    PEDIATRIC BLOOD & CANCER, 2005, 45 (06) : 796 - 801
  • [32] Tumor anaplastic lymphoma kinase (ALK) expression among patients with non-small cell carcinoma of the lung
    Boland, J. M.
    Erdogan, S.
    Vasinalzis, G.
    Yang, P.
    Tillinans, L. S.
    Aubry, M. C.
    Yi, E. S.
    MODERN PATHOLOGY, 2008, 21 : 336A - 337A
  • [33] Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors
    Sim, Jongmin
    Kim, Hyunjin
    Hyeon, Jiyeon
    Choi, Yoon-La
    Han, Joungho
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (15)
  • [34] Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement
    Kim, Hyojin
    Chung, Jin-Haeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 149 - 155
  • [35] Tumor anaplastic lymphoma kinase (ALK) expression among patients with non-small cell carcinoma of the lung
    Boland, J. M.
    Erdogan, S.
    Vasmatzis, G.
    Yang, P.
    Tillmans, L. S.
    Aubry, M. C.
    Yi, E. S.
    LABORATORY INVESTIGATION, 2008, 88 : 336A - 337A
  • [36] Ruxolitinib as monotherapy in a patient with anaplastic lymphoma kinase positive lung adenocarcinoma
    Korsic, Marta
    Mursic, Davorka
    Badovinac, Sonja
    Roglic, Mihovil
    Jakopovic, Marko
    Salek, Silva Zupancic
    Samarzija, Miroslav
    ANTI-CANCER DRUGS, 2019, 30 (10) : 1061 - 1063
  • [37] Inflammatory Myofibroblastic Tumor of the Lung in Children: Anaplastic Lymphoma Kinase (ALK) Expression and Clinico-Pathological Correlation
    Siminovich, Monica
    Galluzzo, Laura
    Lopez, Jessica
    Lubieniecki, Fabiana
    de Davila, Maria Teresa G.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2012, 15 (03) : 179 - 186
  • [38] Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement
    Khanlari, Mahsa
    Tang, Guilin
    Hao, Suyang
    Gong, Yun
    Li, Shaoying
    Miranda, Roberto N.
    Lin, Pei
    Iyer, Swaminathan
    Yin, Cameron C.
    Xie, Wei
    Vega, Francisco
    Medeiros, L. J.
    Xu, Jie
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : E17 - E21
  • [39] Anaplastic Lymphoma Kinase (ALK)-positive Tumors Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma
    Gupta, Rohan
    Amanam, Idoroenyi
    Rahmanuddin, Syed
    Mambetsariev, Isa
    Wang, Yingyu
    Huang, Charity
    Reckamp, Karen
    Vora, Lalit
    Salgia, Ravi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (04): : 337 - 344
  • [40] Identification of a novel LRRC4C-ALK fusion in lung adenocarcinoma and outcome of the response to anaplastic lymphoma kinase inhibitors
    Wang, Hongbiao
    Li, ZhiFeng
    Qi, Xiaofang
    Wang, Wenjing
    Lin, Yingcheng
    JOURNAL OF GENE MEDICINE, 2021, 23 (03):
12345